Dalekos G et al. Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. (Abstract GS-02)
SOF/VEL/VOX effectief en veilig bij hepatitis C na falen op DAA’s
mrt 2020 | Hepatitis